Elexacaftor-Tezacaftor-Ivacaftor Reduces Revision Sinus Surgery in People With Cystic Fibrosis. [PDF]
Lin A +6 more
europepmc +1 more source
Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]
Sinkey RG +6 more
europepmc +1 more source
Biocatalytic Generation of o-Quinone Imines in the Synthesis of 1,4-Benzoxazines and Its Comparative Green Chemistry Metrics. [PDF]
Tehami M +6 more
europepmc +1 more source
Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis. [PDF]
Castaldo A +6 more
europepmc +1 more source
Theratyping as a tool to guide clinical decision-making in patients with suspected cystic fibrosis and variants currently ineligible for CFTR modulator therapy. [PDF]
Gannon RM +10 more
europepmc +1 more source
Ivacaftor affects the susceptibility of standard-of-care drugs used to treat <i>Mycobacterium abscessus</i> lung disease. [PDF]
Shrivastava A +4 more
europepmc +1 more source
Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators. [PDF]
Svedberg M +5 more
europepmc +1 more source
A Broadly Applicable Strategy to Aminate Azines Enabled by Electronically Tuned Phosphine Reagents. [PDF]
Liu RR, Levy JN, McNally A.
europepmc +1 more source
Potential side effects of toxic and restricted substances found in cosmetics declared to be of natural origin. [PDF]
Koncz D +4 more
europepmc +1 more source

